← All diseases
Liver, kidneys and digestion
Liver cirrhosis
Would you like to receive a message when there is new research about Liver cirrhosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Liver cirrhosis is available. View what Premium costs.
Publications and studies (3132)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis. (2018/11/15) ♡
- Yiguanjian decoction enhances fetal liver stem/progenitor cell-mediated repair of liver cirrhosis through regulation of macrophage activation state. (2018/11/14) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Protective Effects of Five Structurally Diverse Flavonoid Subgroups against Chronic Alcohol-Induced Hepatic Damage in a Mouse Model. (2018/11/14) ♡
- c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types. (2018/11/12) ♡
- Ursolic Acid Attenuates Hepatic Steatosis, Fibrosis, and Insulin Resistance by Modulating the Circadian Rhythm Pathway in Diet-Induced Obese Mice. (2018/11/09) ♡
- Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country. (2018/11/08) ♡
- Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study. (2018/11/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Assessment and Management of Nutrition Status in the Hospitalized Patient With Cirrhosis. (2018/11/06) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Balancing Effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R Axis and ACE2-Ang-(1-7)-Mas Axis in Rats with CCl(4)-Induced Hepatic Fibrosis. (2018/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cord-derived mesenchymal stem cells therapy for liver cirrhosis in children with refractory Henoch-Schonlein purpura: A case report. (2018/11/01) ♡
- [Based on traditional Chinese medicine inheritance support system to analyze the regularity of umbilicus application to treat ascites due to cirrhosis]. (2018/11/01) ♡
- Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy. (2018/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Peritoneal Dialysis for Patients with End-Stage Renal Disease and Liver Cirrhosis. (2018/11/01) ♡
- Evaluation of prognostic values of inflammation-based makers in patients with HBV-related acute-on-chronic liver failure. (2018/11/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The ideal diet for patients with liver cirrhosis. (2018/11/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Diffuse reflectance spectroscopy accurately discriminates early and advanced grades of fatty liver in mice. (2018/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary biliary cirrhosis with refractory hypokalemia: A case report. (2018/11/01) ♡
- Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs. (2018/11/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Albumin administration in patients with cirrhosis: Should it be done routinely? (2018/11/01) ♡
- Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis. (2018/10/31) ♡
- Changes in Prealbumin and Body Mass Index Associated with T Lymphocyte Subsets and Nutritional Status in Chronic Hepatitis B and HBV-Cirrhosis Patients. (2018/10/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nutritional support in chronic liver disease and cirrhotics. (2018/10/27) ♡
- Conscious sedation using propofol versus midazolam in cirrhotic patients during upper GI endoscopy: A comparative study. (2018/10/23) ♡
- Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway. (2018/10/18) ♡
- Differences in the genetic backgrounds of patients with alcoholic liver disease and non-alcoholic fatty liver disease. (2018/10/17) ♡
- An Argument for Vitamin D, A, and Zinc Monitoring in Cirrhosis. (2018/10/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy. (2018/10/16) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Diet-Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice. (2018/10/10) ♡
- Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4. (2018/10/05) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Sheng-Jiang Powder Ameliorates High Fat Diet Induced Nonalcoholic Fatty Liver Disease via Inhibiting Activation of Akt/mTOR/S6 Pathway in Rats. (2018/10/04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals. (2018/10/03) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Viral Hepatitis B: clinical, paraclinical and evolutionary features within the Hepatogastroenterology Department at the Aristide Le Dantec Hospital: about 728 cases]. (2018/10/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. PRO: Patients With Advanced Cirrhosis and Portal Vein Thrombosis Should Receive Anticoagulation. (2018/10/02) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CON: Anticoagulation for Portal Vein Thrombosis in Advanced Cirrhosis. (2018/10/02) ♡
- Efficacy of Antiviral Therapy in HBsAg-Positive Pregnant Women to Reduce Mother-to-Infant Transmission of Hepatitis B Virus. (2018/10/01) ♡
- Yu Gan Long reduces rat liver fibrosis by blocking TGF-β1/Smad pathway and modulating the immunity. (2018/10/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. [Effect of bone marrow mesenchymal stem cell transplantation on CCl₄-induced liver injury in rats and intervention effects of Yiguanjian]. (2018/10/01) ♡
- Role of Liver Biopsy in the Diagnosis of Neonatal Cholestasis due to Biliary Atresia. (2018/10/01) ♡
- Pharmacologic Management of Nonalcoholic Steatohepatitis. (2018/10/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [Frequency, clinical profile and mortality of acute-on-chronic liver failure in a public hospital of Lima - Peru]. (2018/10/01) ♡
- A study on the circulating genotypes of hepatitis C virus in a tertiary care hospital in Central Kerala. (2018/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. (2018/10/01) ♡
- Detection of Minimal Hepatic Encephalopathy in Iranian Patients with Cirrhosis. (2018/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A High Serum-Ascites Albumin Gradient and Mediastinal Fibrosarcoma: A Case Report. (2018/10/01) ♡
- Mean standardized uptake value (SUVmean) and global hepatic glycolysis as potential imaging markers reflecting hepatic functional capacity: evidence from 18F-FDG PET/CT. (2018/10/01) ♡
- Inactive hepatitis B carriers: outcomes of patients followed at Hôpital Principal de Dakar, Senegal. (2018/09/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Closing the Quality Chasm in Cirrhosis. (2018/09/07) ♡
- Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice. (2018/09/06) ♡
- Geographical differences exist in high-value care delivery for inpatient management of cirrhosis: Cost conscious care in cirrhosis. (2018/09/04) ♡
- A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis. (2018/09/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.